239 related articles for article (PubMed ID: 8814143)
21. PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration.
Bazan HE; Tao Y
J Ocul Pharmacol Ther; 1997 Jun; 13(3):277-85. PubMed ID: 9185044
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin.
Smith PC; Santibañez JF; Morales JP; Martinez J
J Periodontal Res; 2004 Dec; 39(6):380-7. PubMed ID: 15491342
[TBL] [Abstract][Full Text] [Related]
23. Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors.
Kitange G; Shibata S; Tokunaga Y; Yagi N; Yasunaga A; Kishikawa M; Naito S
Lab Invest; 1999 Apr; 79(4):407-16. PubMed ID: 10211993
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
[TBL] [Abstract][Full Text] [Related]
25. Activation of PAF receptor by oxidised LDL in human monocytes stimulates chemokine releases but not urokinase-type plasminogen activator expression.
Beaudeux JL; Said T; Ninio E; Ganné F; Soria J; Delattre J; Soria C; Legrand A; Peynet J
Clin Chim Acta; 2004 Jun; 344(1-2):163-71. PubMed ID: 15149885
[TBL] [Abstract][Full Text] [Related]
26. Regulation by IL-5 of expression of functional platelet-activating factor receptors on human eosinophils.
Kishimoto S; Shimadzu W; Izumi T; Shimizu T; Fukuda T; Makino S; Sugiura T; Waku K
J Immunol; 1996 Nov; 157(9):4126-32. PubMed ID: 8892648
[TBL] [Abstract][Full Text] [Related]
27. The plasminogen-activating system in hepatic stellate cells.
Leyland H; Gentry J; Arthur MJ; Benyon RC
Hepatology; 1996 Nov; 24(5):1172-8. PubMed ID: 8903394
[TBL] [Abstract][Full Text] [Related]
28. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi.
Rodrigues CO; Dutra PM; Barros FS; Souto-Padrón T; Meyer-Fernandes JR; Lopes AH
Biochem Biophys Res Commun; 1999 Dec; 266(1):36-42. PubMed ID: 10581161
[TBL] [Abstract][Full Text] [Related]
29. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development.
Teesalu T; Blasi F; Talarico D
Dev Dyn; 1998 Sep; 213(1):27-38. PubMed ID: 9733098
[TBL] [Abstract][Full Text] [Related]
30. Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/MEK/SREBP-2 signalling cascade mediated by the PDGFR-beta.
Fuhrman B; Gantman A; Khateeb J; Volkova N; Horke S; Kiyan J; Dumler I; Aviram M
Cardiovasc Res; 2009 Oct; 84(1):145-54. PubMed ID: 19497963
[TBL] [Abstract][Full Text] [Related]
31. Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines.
Solomon A; Li DQ; Lee SB; Tseng SC
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2154-63. PubMed ID: 10892857
[TBL] [Abstract][Full Text] [Related]
32. Keratinocyte growth factor enhances urokinase-type plasminogen activator activity in HPV16 DNA-immortalized human uterine exocervical epithelial cells.
Zheng J; Siren V; Vaheri A
Eur J Cell Biol; 1996 Feb; 69(2):128-34. PubMed ID: 8907612
[TBL] [Abstract][Full Text] [Related]
33. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.
Foca C; Moses EK; Quinn MA; Rice GE
Gynecol Oncol; 2000 Nov; 79(2):244-50. PubMed ID: 11063652
[TBL] [Abstract][Full Text] [Related]
34. Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase.
Rabbani SA; Gladu J; Mazar AP; Henkin J; Goltzman D
J Cell Physiol; 1997 Aug; 172(2):137-45. PubMed ID: 9258335
[TBL] [Abstract][Full Text] [Related]
35. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis.
He J; Bazan HE
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):883-91. PubMed ID: 16505020
[TBL] [Abstract][Full Text] [Related]
36. Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells.
Akai T; Niiya K; Sakuragawa N; Iizuka H; Endo S
J Neurooncol; 2002 Sep; 59(3):193-8. PubMed ID: 12241114
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of cytokine and receptor transcript expression in human corneal and limbal fibroblasts by epidermal growth factor, transforming growth factor-alpha, platelet-derived growth factor B, and interleukin-1 beta.
Li DQ; Tseng SC
Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2068-80. PubMed ID: 8814146
[TBL] [Abstract][Full Text] [Related]
38. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
Bennett SA; Birnboim HC
Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481
[TBL] [Abstract][Full Text] [Related]
39. Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion.
Mazumdar A; Adam L; Boyd D; Kumar R
Cancer Res; 2001 Jan; 61(1):400-5. PubMed ID: 11196194
[TBL] [Abstract][Full Text] [Related]
40. Regulation of urokinase plasminogen activator gene transcription in the RAW264 murine macrophage cell line by macrophage colony-stimulating factor (CSF-1) is dependent upon the level of cell-surface receptor.
Fowles LF; Stacey KJ; Marks D; Hamilton JA; Hume DA
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):313-20. PubMed ID: 10727433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
